cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Stockal+Disclaimer.pdf
1 own
2 watching
Current Price
$10.75
$0.35
(3.37%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
287.67M
52-Week High
52-Week High
20.00000
52-Week Low
52-Week Low
4.00000
Average Volume
Average Volume
0.03M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization287.67M
icon52-Week High20.00000
icon52-Week Low4.00000
iconAverage Volume0.03M
iconDividend Yield--
iconP/E Ratio--
What does the Stockal+Disclaimer.pdf do?
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Read More
News & Events about Stockal+Disclaimer.pdf.
Globe Newswire
1 year ago
INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Announces Achievement of Key Clinical and Regulatory MilestonesAll 115 patients implanted in DREAM U.S. pivotal studyFirst DREAM PMA module submittedFirst patient implanted in ACCCESS U.S. pivotal study Mont-Saint-Guibert, Belgium March 6, 2023, 7:30am ...
Globe Newswire
1 year ago
Nyxoah and Acurable Enter into Distribution Agreement in Germany for the AcuPebble SA100 Home Sleep Test Mont-Saint-Guibert, Belgium August 2, 2022, 8:00am CET / 2:00am ET Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(Nyxoah or the Company), a medical technology company focused on the development and ...
Globe Newswire
1 year ago
REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Receives FDA IDE Approval to Initiate the ACCCESS Study of Genio in Complete Concentric Collapse Patients First ACCCESS patient expected to be implanted in Q4 2022 Mont-Saint-Guibert, Belgium July 11, 2022, 8:00am CET / 2:00am ET Nyxoah SA (Euronext ...
Globe Newswire
1 year ago
REGULATED INFORMATION Nyxoah Reports First Quarter 2022 Financial and Operating Results Mont-Saint-Guibert, Belgium May 10, 2022, 08:50pm CET / 2:50pm ET Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(Nyxoah or the Company), a medical technology company focused on the development and commercialization ...
Globe Newswire
1 year ago
REGULATED INFORMATIONMay 6, 2022, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels: NYXH)Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the Company) Invitation to attend the annual and the extraordinary shareholders meetings of the Company to be held onJune 8, 2022 The board of...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$10.75
$0.35
(3.37%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00